UTHR insider trading: UNITED THERAPEUTICS Corp insider buys & sells

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001082554
Latest public acceptance: Oct 7, 2026, 08:35 PM UTC
Score calculated: Oct 8, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Chairperson & CEO	Common StockSale10b5-117 trades	9,500avg $538.67 / share	$5.12M	Oct 6Filed Oct 7 · 1d later	17 filings 280 @ $527.90 · $147.81KSEC filing 360 @ $528.72 · $190.34KSEC filing 240 @ $530.13 · $127.23KSEC filing 320 @ $531.94 · $170.22KSEC filing 215 @ $533.14 · $114.63KSEC filing 167 @ $534.30 · $89.23KSEC filing 734 @ $535.71 · $393.21KSEC filing 323 @ $536.25 · $173.21KSEC filing 133 @ $537.58 · $71.5KSEC filing 1,088 @ $538.61 · $586.01KSEC filing 1,606 @ $539.68 · $866.72KSEC filing 2,054 @ $540.68 · $1.11MSEC filing 380 @ $541.55 · $205.79KSEC filing 120 @ $542.49 · $65.1KSEC filing 558 @ $543.99 · $303.55KSEC filing 842 @ $544.75 · $458.68KSEC filing 80 @ $545.50 · $43.64KSEC filing
Chairperson & CEO	Common StockSale10b5-13 trades	2,061avg $537.52 / share	$1.11M	Oct 5Filed Oct 6 · 1d later	3 filings 501 @ $536.26 · $268.67KSEC filing 905 @ $537.43 · $486.37KSEC filing 655 @ $538.62 · $352.8KSEC filing

Sale disclosed

United Therapeutics Corporation - Common Stock (UTHR) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Purchase disclosed

United Therapeutics Corporation - Common Stock (UTHR) · Stock

The filing reports a purchase for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

United Therapeutics Corporation - Common Stock (UTHR) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

UTHR

1 purchases · 1919 sales

Insider transactions 2332

Martine A. Rothblatt

Why this buying score?

No qualifying common-equity purchases

Sources and coverage

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Congress transactions 3